TF and neoplasm: Inflammatory cytokine release from cancer cells can cause activation of endothelial cells and monocytes and stimulate the release of TF-positive MP; however, the relative contribution of tumour cells and host cells to the total amount of TF-positive MP observed in cancer patients is unknown.